AMN vs DGX
As of Sep 20, 2026, AMN Healthcare Services (AMN) scores 6.0/10 and Quest Diagnostics (DGX) 6.8/10 on AlphaStocks' five-model composite, so DGX scores higher. DGX trades 24% above its model fair value.
AMN
AMN HEALTHCARE SERVICES INC
6.0
Consider Buy
$34.10
DGX
QUEST DIAGNOSTICS INC
6.8
Consider Buy
$246.52
AMN vs DGX: Which is the Better Investment?
AMN HEALTHCARE SERVICES INC (AMN) scores 6.0/10 while QUEST DIAGNOSTICS INC (DGX) scores 6.8/10 on AlphaStocks' composite model. QUEST DIAGNOSTICS INC has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | AMN | DGX |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.0/10 | 6.8/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $34.10 | $246.52 |
| P/E Ratio | — | 28.1 |
| ROE | -7.9% | 13.8%▲ |
| Market Cap | $1B | $28B |
| Fair Value | — | $199.57 |
| Dividend Yield | — | 1.5% |
| Sector Rank | #49 of 168 | #17 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Caution | Attractive▲ |
| Graham | Caution | Caution |
| Lynch | Attractive▲ | Neutral |
| Greenblatt | Strong▲ | Attractive |
Related comparisons
AMN vs DGX: Which Stock Scores Higher?
AMN HEALTHCARE SERVICES INC (AMN) and QUEST DIAGNOSTICS INC (DGX) are both in the Health Care sector. DGX currently leads with a composite score of 6.8/10 (Consider Buy) compared to AMN's 6.0/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer